Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools

Santulli, Gaetano

doi:10.1124/jpet.122.001457

J Pharmacol Exp Ther

2022

DOI: 10.1124/jpet.122.001457

|View full text |Cite

Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools

Gaetano Santulli

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

2024

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

(2 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…original basic, translational, and clinical research articles, a mini-review, and an editorial. The first Special Section of 2023 (Santulli, 2023) was entitled Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools. This Special Section edited by Gaetano Santulli included 15 featured articles (Ai et al, 2023;Dahariya et al, 2023;El-Daly et al, 2023;Farooqi et al, 2023;Gambardella et al, 2023a,b;Izzo et al, 2023;Liu et al, 2023;Mauro et al, 2023;Mohapatra et al, 2023;Mone et al, 2023;Sangeeth et al, 2023;Traber and Yu, 2023;Wronska, 2023;Yaylım et al, 2023).…”

mentioning

confidence: 99%

Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial

Van Meerveld,

Levi,

Gross

et al. 2024

J Pharmacol Exp Ther

View full text Add to dashboard Cite

Journal of Pharmacology and Experimental Therapeutics (JPET) is one of the leading journals serving the membership of the American Society for Pharmacology and Experimental Therapeutics (ASPET). JPET focuses on the publication of important and ground-breaking innovative science. We publish original research papers and minireviews dealing with interactions of chemicals with biologic systems. All aspects of pharmacology and therapeutics are within the scope of the Journal. Ensuring the highest scientific quality of JPET depends on the hard work of the editor-in-chief, senior associate editors, editorial advisory board members, and reviewers who give so much time to the journal. Effective, fair, and timely reviews of submitted manuscripts are critical for the vibrancy of JPET. We want to take this opportunity to thank all of you who have been involved in the JPET scientific manuscript review process by providing your expertise as a reviewer. Taken together, each of you has provided dedicated scientific service. It is also our pleasure to recognize Mahmood S. Mozaffari for his ASPET Best Reviewer Award. He handled many submissions efficiently and provided consistently high-quality, thoughtful, and constructive recommendation summaries to the authors.As we start the new year, we would like to share with you the latest additions to JPET that we hope will address the future needs of our authors and editors. We have addressed the need to improve the author experience and enhance experimental rigor and reproducibility by adding a simplified author checklist to promote experimental rigor and reproducibility (Table 1). New and Improved Article TypesViewpoint. We have introduced a new article type called Viewpoint (Greenwood-Van Meerveld, 2022) that was introduced to broaden the scientific content of JPET by inviting an author to present a new or unique perspective on a manuscript recently accepted for publication in JPET. The initial goal is to publish at least one Viewpoint per issue coupled with the editorialized article. Recently, due to the interest received, some issues will include two Viewpoints. Viewpoint articles may comment on existing problems, highlight current advances, and briefly speculate future directions of the topic or provide other points of view. The first Viewpoint by Avvisato et al. ( 2023) was published in January 2023.Minireviews. JPET continues to publish Minireviews as a platform for discussing concepts and topics of importance and relevance to pharmacology. Minireview submissions may be invited or unsolicited, and JPET encourages those interested in preparing a Minireview manuscript to complete a Presubmission Inquiry to determine whether the topic lies within the scope of the journal. The JPET Minireview guidelines for authors were revised and updated in July 2023 to provide additional guidance in preparing Minireview manuscripts. Page charges are waived for Minireview submissions.JPET recently launched a new Minireview initiative together with the ASPET Young Scientist Committee to foster the r...

show abstract

mentioning

confidence: 99%

Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial

Van Meerveld,

Levi,

Gross

et al. 2024

J Pharmacol Exp Ther

View full text Add to dashboard Cite

show abstract

“…An increasing body of evidence demonstrates the pivotal role of non-coding RNAs (ncRNAs) in the initiation and progression of DM and CVD ( 3 , 4 ). The ncRNAs represent a group of diverse molecules that are shown to regulate gene expression and have a crucial role in physiological processes such as human growth and development, cell proliferation, apoptosis, and metabolism ( 5 ). The major classes of ncRNAs are microRNAs (miRNAs), long non-coding RNAs (lncRNAs) and circular RNAs (CircRNAs).…”

mentioning

confidence: 99%

Editorial: Non-coding RNA in diabetes and cardiovascular diseases

Mačvanin

Zafirović²,

Obradović³

et al. 2023

Front. Endocrinol.

View full text Add to dashboard Cite

Functions and applications of RNA interference and small regulatory RNAs

Feng,

Guang

2024

ABBS

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Non-Coding RNAs in Clinical Practice: From Biomarkers to Therapeutic Tools

Cited by 3 publications

References 16 publications

Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial

Moving theJournal of Pharmacology and Experimental TherapeuticsForward to Address the Needs of Our Authors and Editors—Editorial

Editorial: Non-coding RNA in diabetes and cardiovascular diseases

Functions and applications of RNA interference and small regulatory RNAs

Contact Info

Product

Resources

About